Bristol-Myers Squibb Company (FRA:BRM)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	47,704	48,300	45,006	46,159	46,385	42,518
Revenue Growth (YoY)	2.57%	7.32%	-2.50%	-0.49%	9.10%	62.62%
Cost of Revenue	12,442	11,949	10,518	10,137	9,940	11,773
Gross Profit	35,262	36,351	34,488	36,022	36,445	30,745
Selling, General & Admin	7,227	7,865	7,678	7,777	7,655	7,618
Research & Development	9,639	9,782	9,112	9,509	10,195	10,048
Operating Expenses	22,625	26,519	25,837	26,881	27,873	27,354
Operating Income	12,637	9,832	8,651	9,141	8,572	3,391
Interest Expense	-1,991	-1,958	-1,161	-1,205	-1,303	-1,381
Interest & Investment Income	485	478	449	171	39	121
Earnings From Equity Investments	44	44	-38	-108	231	72
Currency Exchange Gain (Loss)	31	31	160	148	32	23
Other Non Operating Income (Expenses)	1,621	1,481	2,119	1,827	1,708	1,528
EBT Excluding Unusual Items	12,827	9,908	10,180	9,974	9,279	3,754
Merger & Restructuring Charges	-1,036	-1,968	-893	-520	-724	-1,255
Gain (Loss) on Sale of Investments	-337	-28	-122	-693	514	1,157
Gain (Loss) on Sale of Assets	-15	-15	-	211	9	55
Asset Writedown	-2,249	-2,819	-107	-	-	-
Legal Settlements	-272	-84	-10	-178	-82	194
Other Unusual Items	-336	-	305	-266	261	1,757
Pretax Income	6,595	-8,379	8,440	7,713	8,098	-6,871
Income Tax Expense	1,529	554	400	1,368	1,084	2,124
Earnings From Continuing Operations	5,066	-8,933	8,040	6,345	7,014	-8,995
Minority Interest in Earnings	-17	-15	-15	-18	-20	-20
Net Income	5,049	-8,948	8,025	6,327	6,994	-9,015
Net Income to Common	5,049	-8,948	8,025	6,327	6,994	-9,015
Net Income Growth	-	-	26.84%	-9.54%	-	-
Shares Outstanding (Basic)	2,031	2,027	2,069	2,130	2,221	2,258
Shares Outstanding (Diluted)	2,034	2,027	2,078	2,146	2,245	2,258
Shares Change (YoY)	0.03%	-2.45%	-3.17%	-4.41%	-0.58%	31.89%
EPS (Basic)	2.49	-4.41	3.88	2.97	3.15	-3.99
EPS (Diluted)	2.49	-4.41	3.86	2.95	3.12	-3.99
EPS Growth	-	-	30.85%	-5.45%	-	-
Free Cash Flow	-	13,942	12,651	11,948	15,234	13,299
Free Cash Flow Per Share	-	6.88	6.09	5.57	6.79	5.89
Dividend Per Share	2.460	2.420	2.310	2.190	2.010	1.840
Dividend Growth	3.80%	4.76%	5.48%	8.96%	9.24%	9.52%
Gross Margin	73.92%	75.26%	76.63%	78.04%	78.57%	72.31%
Operating Margin	26.49%	20.36%	19.22%	19.80%	18.48%	7.98%
Profit Margin	10.58%	-18.53%	17.83%	13.71%	15.08%	-21.20%
Free Cash Flow Margin	-	28.87%	28.11%	25.88%	32.84%	31.28%
EBITDA	19,116	19,407	18,420	19,423	19,329	13,824
EBITDA Margin	40.07%	40.18%	40.93%	42.08%	41.67%	32.51%
D&A For EBITDA	6,479	9,575	9,769	10,282	10,757	10,433
EBIT	12,637	9,832	8,651	9,141	8,572	3,391
EBIT Margin	26.49%	20.36%	19.22%	19.80%	18.48%	7.98%
Effective Tax Rate	23.18%	-	4.74%	17.74%	13.39%	-
Revenue as Reported	47,704	48,300	45,006	46,159	46,385	42,518
Advertising Expenses	-	1,500	1,400	1,300	1,300	990

Source: S&P Global Market Intelligence. Standard template. Financial Sources.